Abstract
SummaryThe potential heath‐benefitting bioactivities of rice bran albumin hydrolysates were investigated. The antioxidant and α‐glucosidase‐ and angiotensin‐converting enzyme (ACE)‐inhibitory activities of the crude hydrolysates and their fractions were determined. The fractions with the highest bioactivities were analysed by liquid chromatography–tandem mass spectrometry/mass spectrometry to identify the active peptide sequences. Hydrolysates produced by commercial proteases Alcalase and Protamax exhibited the highest α‐glucosidase‐ and ACE‐inhibitory activities, resulting in 43.1 ± 2.1% and 54.4 ± 5.1% inhibition of the enzymes, respectively. Inhibitory activities against both enzymes were highest in the MW<3‐kDa fractions that were eluted under alkaline conditions. A number of peptide sequences were identified in the fractions, which contained several sequences with reported α‐glucosidase‐ or ACE‐inhibitory activities. This is the first time that such activities are reported for rice bran albumin hydrolysate, and it demonstrated that the hydrolysates may be developed into nutraceuticals useful in managing diabetics and hypertension.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Food Science & Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
